EP Patent

EP2323634A1 — Ropinirole composition

Assigned to KRKA dd · Expires 2011-05-25 · 15y expired

What this patent protects

The present invention relates to novel pharmaceutical composition comprising ropinirole or its salt, hydrophilic matrix former, hydrophilic release rate modifier and optionally other excipients.

USPTO Abstract

The present invention relates to novel pharmaceutical composition comprising ropinirole or its salt, hydrophilic matrix former, hydrophilic release rate modifier and optionally other excipients.

Drugs covered by this patent

venlafaxine-besylate (VENLAFAXINE BESYLATE)

Patent Metadata

Patent number: EP2323634A1
Jurisdiction: EP
Classification: —
Expires: 2011-05-25
Drug substance claim: No
Drug product claim: No
Assignee: KRKA dd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.